Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres

Vaccine

Volumn 14, Issue 11, 1996, Pages 1031-1038

  Yan, Changhong ^a   Rill, Wayne L ^a   Malli, Robert ^a   Hewetson, John ^a   Naseem, Hina ^a   Tammariello, Ralph ^a   Kende, Meir ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Intranasal immunization; Poly(lactide co glycolide) microspheres; Ricin toxoid vaccine; Systemic and mucosal antibodies

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; MICROSPHERE; POLYGLACTIN; RICIN; VACCINE;

AEROSOL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTOXICATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030218606     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00063-1     Document Type: Article

References (28)

1. 1 Morris, W., Steinhoff, M.C. and Russell, P.K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994, 12, 5
2. 2 Van, C., Rill, W.L., Malli, R., Hewetson, J., Tammariello, R. and Kende, M. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers. Vaccine 1995, 13, 645
3. 3 Alonso, M.J., Gupta, R.K., Min, C., Siber, G.R. and Langer, R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994, 12, 299
4. 4 O'Hagan, D.T., Rahman, D. and McGee, J.P. et al. Biodegradable microparticles as controlled release antigen delivery systems. Immunology 1991, 73, 239
5. 5 Kende, M., Van, C., Rill, W. et al. Oral delivery of ricin toxoid (RT) vaccine in microspheres stimulates protective IgA and IgG2a antibodies. Proc. 22nd Int. Symp. Control Rel. Bioact. Mater. 1995, Seattle, WA, USA
6. 6 O'Hagan, D.T., Palin, K., Davis, S.S., Artursson, P. and Sjoholm, I. Microparticles as potentially orally active immunological adjuvants. Vaccine 1989, 7, 213
7. 7 Su, K.S.E. In: Peptide and Protein Drug Delivery (Ed. Lee, V.H.L.). Marcel Dekker, New York, 1991, p. 595
8. 8 Cahill, E.S., O'Hagan, D.T., Illum, L., Barnard, A., Mills, K.H.G. and Redhead, K. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine 1995, 13, 455
9. 9 Abraham, E. Intranasal immunization with bacterial polysaccharide containing liposomes enhanced antigen-specific pulmonary secretory antibody response. Vaccine 1992, 10, 461
10. 10 Aramaki, Y., Fujii, Y., Yachi, K., Kikuchi, H. and Tsuchiya, S. Activation of systemic and mucosal immune response following nasal administration of liposomes. Vaccine 1994, 12, 1241
11. 11 Guink, N., Kris, R.M., Goodman-Snitkoff, G., Small, P.A. Jr and Mannino, R.J. Intranasal immunization with proteoliposomes protects against influenza. Vaccine 1989, 7, 147
12. 12 de Haan, A., Geerligs, H.J., Huchshorn, J.P., van Scharrenburg, G.J.M., Palache, A.M. and Wilschut, J. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an infuenza subunit vaccine and coadministered liposomes. Vaccine 1995, 13, 155
13. 13 Assaad, A.W., Wilhelmsen, C. and Pitt, L. et al. Ricin, a plant toxin, induces an acute lung injury and high permeability pulmonary edema in rats. Am. Rev. Respir. Dis. 1993, 147, A361
14. 14 Langford, M.J., Pitt, L. and Jaax, N.K. Pulmonary lesions in adult male rats exposed to an acute lethal dose of aerosolized ricin. Vet Path. 1993, 30, 479
15. 15 Assaad, A.W., Parker, G. and Wilhelmsen, C. et al. Ricin, a novel pulmonary toxin by inhalation: evidence that primary pulmonary toxicity is the major determinant of morbidity and mortality. Am. J. Repir. Crit. Care Med. 1994, 149, A1027
16. 16 Wilhelmsen, C. and Pitt, L. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet. Path. 1993, 30, 482
17. 17 Hewetson, I.F., Assaad, A.W., Kokes, J.M. and Teters, D.R. Ricin-specific antibodies in the bronchioalveolar lavage of rats immunized with a GMP ricin toxoid protect against inhaled ricin. FASEB J. 1995, 9, 3973: A685
18. 18 Hewetson, J.F., Rivera, V.R., Lemley, P.V., Pitt, M.L., Creasia, D.A. and Thompson, W.L. A formalinized toxoid for protection of mice from inhaled ricin. Vaccine Res. (Submitted for publication)
19. 19 Yan, C., Resau, J.H., Hewetson, J., West, M., Rill, W.L. and Kende, M. Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. J. Contr. Rel. 1994, 32, 231
20. 20 Guyton, A.C. Measurement of the respiratory volumes of laboratory animals. Am. J. Phys. 1947, 150, 70
21. 21 Bernstein, I.D., Nowinski, R.C., Tarn, M.R., McMaster, B., Houston, L.L. and Clark, E.A. In: Monoclonal Antibodies (Eds Kennett, R.H., Kearn, T.J. and Bechtol, K.B.). Plenum Press, New York, 1980, p. 275
22. 22 Herlyn, D. and Kaprowski, H. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc. Natl Acad. Sci. USA 1982, 76, 4761
23. 23 Seto, M., Takahashi, T., Nakamura, S., Matsudaira, Y. and nishizuka, Y. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes. Cancer Res. 1983, 43, 4768
24. 24 Wechsler, D.S. and Kongshavn, P.A.L. Heat-labile IgG2a antibodies affect cure of trypanosoma musculi infection in C57BL/6 mice. J. Immun. 1986, 137, 2968
25. 25 Byars, N.E., Nakano, G., Welch, M., Lehman, D. and Allison, A.C. Improvement of hepatitis B vaccine by the use of a new adjuvant. Vaccine 1991, 9, 309
26. 26 Allison, A.C. and Byars, N.E. Immunological adjuvants: desirable properties and side effects. Molec. Immun. 1991, 28, 279
27. 27 Walker, R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994, 12, 387
28. 28 Eldridge, J.H., Hammond, C.J., Meulbroek, J.A., Staas, J.K., Gilley, R.M. and Tice, T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Pever's patches. J. Contr. Rel. 1990, 11, 205